Aethlon Medical (AEMD) Reports In-Line Q2 EPS

Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.19), in-line with the analyst estimate of ($0.19).

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Change in Nonfarm Payrolls (Aug) 162K vs 55K Expected, Unemployment Rate 4.1%